Go Pro

PACS Group (PACS) Financials

PACS Group logo
$44.76 +0.17 (+0.37%)
Closing price 03:59 PM Eastern
Extended Trading
$44.80 +0.03 (+0.08%)
As of 06:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for PACS Group

Annual Income Statements for PACS Group

This table shows PACS Group's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
150 113 56 192
Consolidated Net Income / (Loss)
150 113 55 191
Net Income / (Loss) Continuing Operations
150 113 55 191
Total Pre-Tax Income
207 157 102 284
Total Operating Income
229 208 123 310
Total Gross Profit
561 664 793 1,159
Total Revenue
2,422 3,111 4,090 5,289
Operating Revenue
2,422 3,111 4,090 5,289
Total Cost of Revenue
1,861 2,448 3,297 4,130
Operating Cost of Revenue
1,861 2,448 3,297 4,130
Total Operating Expenses
331 456 670 850
Selling, General & Admin Expense
149 214 344 415
Depreciation Expense
22 26 41 56
Other Operating Expenses / (Income)
160 217 285 379
Total Other Income / (Expense), net
-22 -50 -22 -25
Interest Expense
26 50 44 28
Other Income / (Expense), net
3.22 -0.54 23 3.22
Income Tax Expense
57 44 46 93
Net Income / (Loss) Attributable to Noncontrolling Interest
0.00 0.01 -0.42 -0.08
Basic Earnings per Share
$1.17 $0.88 $0.38 $1.23
Weighted Average Basic Shares Outstanding
128.72M 128.72M 146.66M 156.18M
Diluted Earnings per Share
$1.17 $0.88 $0.38 $1.22
Weighted Average Diluted Shares Outstanding
128.72M 128.72M 148.57M 156.70M
Weighted Average Basic & Diluted Shares Outstanding
- - - 157.17M

Quarterly Income Statements for PACS Group

This table shows PACS Group's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders
34 35 -32 16 37 28 51 52 60 81 76
Consolidated Net Income / (Loss)
34 35 -32 16 36 28 51 52 60 81 76
Net Income / (Loss) Continuing Operations
34 35 -32 16 36 28 51 52 60 81 76
Total Pre-Tax Income
49 58 -51 34 61 43 79 76 87 114 106
Total Operating Income
63 65 -37 23 72 48 80 86 95 120 109
Total Gross Profit
174 184 174 177 259 253 288 298 319 346 338
Total Revenue
853 920 936 1,026 1,208 1,277 1,309 1,345 1,358 1,420 1,428
Operating Revenue
853 920 936 1,026 1,208 1,277 1,309 1,345 1,358 1,420 1,428
Total Cost of Revenue
680 736 762 850 949 1,024 1,021 1,046 1,039 1,075 1,090
Operating Cost of Revenue
680 736 762 850 949 1,024 1,021 1,046 1,039 1,075 1,090
Total Operating Expenses
111 119 211 154 187 205 208 212 225 226 229
Selling, General & Admin Expense
42 47 137 71 90 99 100 103 113 112 114
Depreciation Expense
7.28 8.12 9.25 11 13 13 13 14 15 18 20
Other Operating Expenses / (Income)
62 64 65 73 84 94 94 95 96 96 95
Total Other Income / (Expense), net
-13 -7.61 -14 11 -11 -5.41 -1.89 -9.97 -7.88 -6.30 -3.49
Interest Expense
14 16 9.92 9.03 9.30 6.90 4.35 8.53 8.58 6.42 6.04
Other Income / (Expense), net
0.46 8.49 -3.91 20 -1.48 1.49 2.47 -1.44 0.70 0.13 2.55
Income Tax Expense
15 23 -19 17 25 14 28 24 27 33 29
Net Income / (Loss) Attributable to Noncontrolling Interest
0.00 0.00 0.00 0.59 -1.01 -0.09 0.00 -0.08 0.08 -0.03 -0.02
Basic Earnings per Share
$0.28 $0.27 ($0.21) $0.10 $0.22 $0.18 $0.33 $0.33 $0.39 $0.51 $0.48
Weighted Average Basic Shares Outstanding
128.72M 128.72M 149.46M 153.12M 146.66M 155.18M 156.34M 156.58M 156.18M 157.07M 158.11M
Diluted Earnings per Share
$0.28 $0.27 ($0.21) $0.10 $0.22 $0.17 $0.31 $0.32 $0.42 $0.50 $0.47
Weighted Average Diluted Shares Outstanding
128.72M 128.72M 149.46M 158.45M 148.57M 166.42M 165.47M 164.71M 156.70M 162.08M 161.99M
Weighted Average Basic & Diluted Shares Outstanding
0.00 24.64M 152.40M - 0.00 - - 156.62M 157.17M 158.27M 158.34M

Annual Cash Flow Statements for PACS Group

This table details how cash moves in and out of PACS Group's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
30 20 42 71
Net Cash From Operating Activities
93 64 367 404
Net Cash From Continuing Operating Activities
93 64 367 404
Net Income / (Loss) Continuing Operations
150 113 55 191
Consolidated Net Income / (Loss)
150 113 55 191
Depreciation Expense
22 26 41 56
Amortization Expense
1.21 6.07 3.12 3.15
Non-Cash Adjustments To Reconcile Net Income
15 21 133 97
Changes in Operating Assets and Liabilities, net
-96 -102 135 57
Net Cash From Investing Activities
-75 -173 -443 -264
Net Cash From Continuing Investing Activities
-75 -173 -443 -264
Purchase of Property, Plant & Equipment
-78 -173 -350 -249
Acquisitions
0.00 -2.60 -33 0.00
Purchase of Investments
0.00 0.00 -91 -21
Sale of Property, Plant & Equipment
0.01 0.75 1.50 0.75
Sale and/or Maturity of Investments
0.00 0.00 26 0.00
Other Investing Activities, net
- 1.86 3.52 5.59
Net Cash From Financing Activities
12 130 117 -69
Net Cash From Continuing Financing Activities
12 130 117 -69
Repayment of Debt
-173 -1,058 -1,073 -60
Payment of Dividends
-60 -80 -34 -0.38
Issuance of Debt
242 1,267 748 0.00
Issuance of Common Equity
3.25 0.59 510 0.00
Other Financing Activities, net
0.00 0.00 -34 -8.40
Cash Interest Paid
26 51 48 41
Cash Income Taxes Paid
43 60 108 84

Quarterly Cash Flow Statements for PACS Group

This table details how cash moves in and out of PACS Group's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents
9.63 29 -25 -15 -16 99 130 7.04 -127 42 -97
Net Cash From Operating Activities
15 -9.70 59 35 209 65 150 53 -3.39 236 136
Net Cash From Continuing Operating Activities
15 -9.70 59 35 209 65 150 53 -3.39 236 136
Net Income / (Loss) Continuing Operations
20 34 35 -11 -19 36 28 51 60 81 76
Consolidated Net Income / (Loss)
20 34 35 -11 -19 36 28 51 60 81 76
Depreciation Expense
6.36 7.28 8.12 8.78 11 13 13 13 15 18 20
Amortization Expense
0.55 1.24 0.78 0.78 0.78 0.78 0.79 0.79 0.79 0.79 0.79
Non-Cash Adjustments To Reconcile Net Income
6.08 6.74 6.86 102 27 26 24 25 26 31 35
Changes in Operating Assets and Liabilities, net
-18 -59 8.18 -65 189 -11 85 -37 -106 106 3.33
Net Cash From Investing Activities
-46 -60 -119 -121 -99 -104 -16 -32 -118 -127 -156
Net Cash From Continuing Investing Activities
-46 -60 -119 -121 -99 -104 -16 -32 -118 -127 -156
Purchase of Property, Plant & Equipment
-46 -58 -89 -111 -66 -83 -18 -19 -114 -108 -131
Purchase of Investments
- - -25 -10 -10 -46 0.00 -15 -6.05 -20 -43
Divestitures
- - 0.67 - - 1.31 1.30 1.52 - 1.44 1.32
Net Cash From Financing Activities
40 98 34 71 -126 139 -4.07 -13 -5.47 -68 -77
Net Cash From Continuing Financing Activities
40 98 34 71 -126 139 -4.07 -13 -5.47 -68 -77
Repayment of Debt
-100 -498 -105 -465 -366 -138 -4.07 -4.96 -5.47 -101 -65
Issuance of Debt
165 608 157 171 144 276 0.00 - - 45 17
Other Financing Activities, net
- - - - - 0.00 0.00 -7.96 - -11 -29
Cash Interest Paid
7.39 15 16 9.91 14 8.90 8.09 9.87 12 9.10 8.16
Cash Income Taxes Paid
35 8.17 0.00 43 34 30 0.36 80 3.00 0.33 23

Annual Balance Sheets for PACS Group

This table presents PACS Group's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Total Assets
3,513 5,243 5,584
Total Current Assets
722 938 1,070
Cash & Equivalents
73 158 197
Accounts Receivable
600 717 702
Prepaid Expenses
49 64 171
Plant, Property, & Equipment, net
578 991 1,201
Total Noncurrent Assets
2,213 3,314 3,313
Goodwill
65 67 68
Other Noncurrent Operating Assets
2,148 3,247 3,245
Total Liabilities & Shareholders' Equity
3,513 5,243 5,584
Total Liabilities
3,411 4,527 4,632
Total Current Liabilities
457 978 1,001
Short-Term Debt
17 157 4.46
Accounts Payable
141 175 192
Accrued Expenses
70 142 154
Current Employee Benefit Liabilities
92 146 188
Other Current Liabilities
137 358 463
Total Noncurrent Liabilities
2,954 3,549 3,630
Long-Term Debt
716 251 345
Asset Retirement Reserve & Litigation Obligation
146 165 193
Other Noncurrent Operating Liabilities
2,092 3,133 3,093
Commitments & Contingencies
0.00 0.00 0.00
Total Equity & Noncontrolling Interests
102 716 952
Total Preferred & Common Equity
96 710 947
Total Common Equity
96 710 947
Common Stock
0.13 592 637
Retained Earnings
96 118 310
Noncontrolling Interest
5.60 6.14 5.68

Quarterly Balance Sheets for PACS Group

This table presents PACS Group's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets
3,861 3,933 4,517 5,494 5,502 5,627 5,664 5,656
Total Current Assets
821 764 735 1,081 1,077 1,127 1,068 962
Cash & Equivalents
81 73 50 288 294 356 248 164
Accounts Receivable
678 631 624 742 690 695 733 724
Prepaid Expenses
62 60 61 52 93 76 87 74
Plant, Property, & Equipment, net
667 857 925 999 1,032 0.00 1,308 1,397
Total Noncurrent Assets
2,373 2,312 2,857 3,414 3,392 4,500 3,287 3,297
Goodwill
65 65 65 67 67 68 68 68
Other Noncurrent Operating Assets
2,308 2,247 2,792 3,347 3,325 4,432 3,219 3,228
Total Liabilities & Shareholders' Equity
3,861 3,933 4,517 5,494 5,502 5,627 5,664 5,656
Total Liabilities
3,741 3,390 3,850 4,738 4,690 4,750 4,621 4,541
Total Current Liabilities
535 488 682 1,107 1,167 1,198 1,074 1,055
Short-Term Debt
17 16 16 155 152 107 8.39 7.38
Accounts Payable
157 126 155 199 172 205 181 161
Accrued Expenses
71 75 107 164 248 179 168 205
Current Employee Benefit Liabilities
144 99 155 210 193 253 243 188
Other Current Liabilities
147 172 249 379 402 453 473 494
Total Noncurrent Liabilities
2,662 2,647 3,168 3,631 3,522 3,552 3,548 3,486
Long-Term Debt
231 227 254 249 247 246 285 239
Asset Retirement Reserve & Litigation Obligation
155 172 188 187 208 177 209 238
Other Noncurrent Operating Liabilities
2,276 2,248 2,726 3,195 3,068 3,129 3,054 3,009
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
119 543 667 756 813 877 1,042 1,115
Total Preferred & Common Equity
114 537 660 750 807 871 1,037 1,110
Total Common Equity
113 537 660 750 807 871 1,037 1,110
Common Stock
0.13 472 579 604 609 621 647 644
Retained Earnings
113 65 81 147 197 250 390 467
Noncontrolling Interest
5.60 6.11 6.70 6.05 5.83 5.59 5.02 5.00

Annual Metrics And Ratios for PACS Group

This table displays calculated financial ratios and metrics derived from PACS Group's official financial filings.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - -
Revenue Growth
0.00% 28.47% 31.44% 29.32%
EBITDA Growth
0.00% -6.70% -20.56% 95.78%
EBIT Growth
0.00% -10.90% -29.60% 114.41%
NOPAT Growth
0.00% -10.58% -55.01% 210.69%
Net Income Growth
0.00% -24.99% -50.97% 245.95%
EPS Growth
0.00% -24.79% -56.82% 221.05%
Operating Cash Flow Growth
0.00% -31.22% 476.70% 10.04%
Free Cash Flow Firm Growth
0.00% 0.00% 77.45% 150.41%
Invested Capital Growth
0.00% 0.00% 26.95% 14.38%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00%
Profitability Metrics
- - - -
Gross Margin
23.15% 21.33% 19.38% 21.92%
EBITDA Margin
10.57% 7.68% 4.64% 7.03%
Operating Margin
9.47% 6.68% 3.01% 5.85%
EBIT Margin
9.60% 6.66% 3.57% 5.91%
Profit (Net Income) Margin
6.21% 3.63% 1.35% 3.62%
Tax Burden Percent
72.69% 71.75% 54.50% 67.31%
Interest Burden Percent
89.02% 75.91% 69.61% 90.93%
Effective Tax Rate
27.31% 28.25% 45.50% 32.69%
Return on Invested Capital (ROIC)
0.00% 39.19% 7.77% 20.13%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 28.20% 5.19% 11.72%
Return on Net Nonoperating Assets (RNNOA)
0.00% 182.74% 5.77% 2.83%
Return on Equity (ROE)
0.00% 221.93% 13.54% 22.96%
Cash Return on Invested Capital (CROIC)
0.00% -160.81% -15.98% 6.72%
Operating Return on Assets (OROA)
0.00% 5.90% 3.33% 5.78%
Return on Assets (ROA)
0.00% 3.21% 1.26% 3.54%
Return on Common Equity (ROCE)
0.00% 209.72% 13.35% 22.79%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
167 149 67 208
NOPAT Margin
6.88% 4.79% 1.64% 3.94%
Net Nonoperating Expense Percent (NNEP)
0.00% 10.99% 2.58% 8.41%
Return On Investment Capital (ROIC_SIMPLE)
- 17.87% 5.97% 16.01%
Cost of Revenue to Revenue
76.85% 78.67% 80.62% 78.08%
SG&A Expenses to Revenue
6.15% 6.87% 8.41% 7.85%
R&D to Revenue
0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
13.68% 14.66% 16.37% 16.06%
Earnings before Interest and Taxes (EBIT)
233 207 146 313
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
256 239 190 372
Valuation Ratios
- - - -
Price to Book Value (P/BV)
0.00 4.68 2.82 6.35
Price to Tangible Book Value (P/TBV)
0.00 14.59 3.11 6.84
Price to Revenue (P/Rev)
0.19 0.14 0.49 1.14
Price to Earnings (P/E)
2.99 3.99 35.83 31.39
Dividend Yield
0.00% 0.00% 0.00% 0.00%
Earnings Yield
33.44% 25.08% 2.79% 3.19%
Enterprise Value to Invested Capital (EV/IC)
0.00 1.47 2.33 5.59
Enterprise Value to Revenue (EV/Rev)
0.00 0.36 0.55 1.17
Enterprise Value to EBITDA (EV/EBITDA)
0.00 4.67 11.88 16.60
Enterprise Value to EBIT (EV/EBIT)
0.00 5.38 15.45 19.73
Enterprise Value to NOPAT (EV/NOPAT)
0.00 7.48 33.61 29.61
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 17.50 6.14 15.26
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 88.73
Leverage & Solvency
- - - -
Debt to Equity
0.00 7.20 0.57 0.37
Long-Term Debt to Equity
0.00 7.04 0.35 0.36
Financial Leverage
0.00 6.48 1.11 0.24
Leverage Ratio
0.00 34.53 10.71 6.49
Compound Leverage Factor
0.00 26.21 7.46 5.90
Debt to Total Capital
0.00% 87.81% 36.30% 26.83%
Short-Term Debt to Total Capital
0.00% 2.02% 13.96% 0.34%
Long-Term Debt to Total Capital
0.00% 85.79% 22.34% 26.49%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.67% 0.55% 0.44%
Common Equity to Total Capital
0.00% 11.52% 63.15% 72.73%
Debt to EBITDA
0.00 3.07 2.15 0.94
Net Debt to EBITDA
0.00 2.76 1.32 0.41
Long-Term Debt to EBITDA
0.00 3.00 1.32 0.93
Debt to NOPAT
0.00 4.91 6.08 1.68
Net Debt to NOPAT
0.00 4.42 3.73 0.73
Long-Term Debt to NOPAT
0.00 4.80 3.74 1.65
Altman Z-Score
0.00 1.29 1.16 2.00
Noncontrolling Interest Sharing Ratio
0.00% 5.51% 1.44% 0.71%
Liquidity Ratios
- - - -
Current Ratio
0.00 1.58 0.96 1.07
Quick Ratio
0.00 1.47 0.89 0.90
Cash Flow Metrics
- - - -
Free Cash Flow to Firm (FCFF)
0.00 -612 -138 70
Operating Cash Flow to CapEx
118.39% 37.02% 105.46% 162.73%
Free Cash Flow to Firm to Interest Expense
0.00 -12.25 -3.11 2.45
Operating Cash Flow to Interest Expense
3.63 1.28 8.28 14.25
Operating Cash Flow Less CapEx to Interest Expense
0.56 -2.17 0.43 5.49
Efficiency Ratios
- - - -
Asset Turnover
0.00 0.89 0.93 0.98
Accounts Receivable Turnover
0.00 5.19 6.21 7.46
Inventory Turnover
0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 5.39 0.00 4.83
Accounts Payable Turnover
0.00 17.37 20.87 22.49
Days Sales Outstanding (DSO)
0.00 70.39 58.75 48.95
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 21.02 17.49 16.23
Cash Conversion Cycle (CCC)
0.00 49.37 41.26 32.72
Capital & Investment Metrics
- - - -
Invested Capital
0.00 761 966 1,105
Invested Capital Turnover
0.00 8.18 4.74 5.11
Increase / (Decrease) in Invested Capital
0.00 761 205 139
Enterprise Value (EV)
0.00 1,115 2,254 6,170
Market Capitalization
450 450 1,998 6,012
Book Value per Share
$0.00 $0.75 $4.66 $6.05
Tangible Book Value per Share
$0.00 $0.24 $4.22 $5.61
Total Capital
0.00 834 1,124 1,302
Total Debt
0.00 733 408 349
Total Long-Term Debt
0.00 716 251 345
Net Debt
0.00 659 250 152
Capital Expenditures (CapEx)
78 172 348 248
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 209 -41 -124
Debt-free Net Working Capital (DFNWC)
0.00 282 117 73
Net Working Capital (NWC)
0.00 265 -40 68
Net Nonoperating Expense (NNE)
16 36 12 17
Net Nonoperating Obligations (NNO)
0.00 659 250 152
Total Depreciation and Amortization (D&A)
24 32 44 59
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 6.71% -1.00% -2.35%
Debt-free Net Working Capital to Revenue
0.00% 9.06% 2.85% 1.38%
Net Working Capital to Revenue
0.00% 8.52% -0.98% 1.29%
Earnings Adjustments
- - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $0.38 $1.23
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 146.66M 156.18M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.38 $1.22
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 148.57M 156.70M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 0.00 157.17M
Normalized Net Operating Profit after Tax (NOPAT)
167 149 67 208
Normalized NOPAT Margin
6.88% 4.79% 1.64% 3.94%
Pre Tax Income Margin
8.55% 5.06% 2.48% 5.38%
Debt Service Ratios
- - - -
EBIT to Interest Expense
9.11 4.15 3.29 11.03
NOPAT to Interest Expense
6.53 2.99 1.51 7.35
EBIT Less CapEx to Interest Expense
6.04 0.70 -4.56 2.27
NOPAT Less CapEx to Interest Expense
3.47 -0.46 -6.34 -1.41
Payout Ratios
- - - -
Dividend Payout Ratio
40.05% 71.22% 60.93% 0.20%
Augmented Payout Ratio
40.05% 71.22% 60.93% 0.20%

Quarterly Metrics And Ratios for PACS Group

This table displays calculated financial ratios and metrics derived from PACS Group's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding
- - - - - - - - - 157,165,029.00 158,272,376.00
DEI Adjusted Shares Outstanding
- - - - - - - - - 157,165,029.00 158,272,376.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - 0.51 0.48
Growth Metrics
- - - - - - - - - - -
Revenue Growth
0.00% 31.94% 29.08% 0.00% 0.00% 38.85% 39.92% 31.01% 12.43% 11.22% 9.07%
EBITDA Growth
0.00% 46.76% -88.79% 0.00% 0.00% -23.66% 411.75% 81.46% 32.49% 120.23% 36.99%
EBIT Growth
0.00% 48.06% -106.81% 0.00% 0.00% -32.74% 301.94% 98.72% 35.30% 142.09% 34.85%
NOPAT Growth
0.00% 18.45% -98.51% 0.00% 0.00% -18.87% 300.53% 434.98% 53.19% 166.27% 51.12%
Net Income Growth
0.00% 30.70% -151.40% 0.00% 0.00% -18.49% 259.89% 222.83% 65.19% 184.24% 49.80%
EPS Growth
0.00% 31.03% -143.75% 0.00% 0.00% -37.04% 247.62% 220.00% 90.91% 194.12% 51.61%
Operating Cash Flow Growth
0.00% -25.86% 265.16% 0.00% 0.00% 155.73% 0.00% 0.00% -105.25% 57.30% 157.75%
Free Cash Flow Firm Growth
0.00% 0.00% 0.00% 0.00% 0.00% 98.56% 110.24% 0.00% 54.67% -1,040.96% -297.15%
Invested Capital Growth
0.00% 0.00% 0.00% 0.00% 0.00% 5.22% -5.12% 0.00% 14.38% 24.59% 30.45%
Revenue Q/Q Growth
8.11% 0.00% 5.04% 4.53% 17.69% 0.00% 0.00% 0.00% 1.00% 4.60% 0.53%
EBITDA Q/Q Growth
60.61% 0.00% -93.45% 760.19% 53.98% 0.00% 0.00% 0.00% 12.42% 24.62% -4.49%
EBIT Q/Q Growth
67.48% 0.00% -103.61% 1,435.99% 65.16% 0.00% 0.00% 0.00% 12.45% 25.97% -6.89%
NOPAT Q/Q Growth
63.76% 0.00% -99.08% 2,125.42% 284.86% 0.00% 0.00% 0.00% 10.20% 30.56% -7.36%
Net Income Q/Q Growth
71.31% 0.00% -122.20% 248.61% 123.26% 0.00% 0.00% 0.00% 14.25% 34.93% -5.35%
EPS Q/Q Growth
86.67% 0.00% -118.42% 242.86% 120.00% 0.00% 0.00% 0.00% 31.25% 19.05% -6.00%
Operating Cash Flow Q/Q Growth
-163.88% 0.00% -40.78% 500.78% -69.12% 0.00% 0.00% 0.00% 0.00% 7,071.53% -42.66%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% -27.06% 100.00% 0.00% 0.00% 0.00% 0.00% 90.97% -75.81% -54.90%
Invested Capital Q/Q Growth
0.00% 0.00% 18.95% -100.00% 0.00% 0.00% 0.00% 0.00% 26.31% -1.57% 10.08%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
20.34% 21.26% 22.38% 17.22% 21.40% 19.84% 22.02% 22.19% 23.51% 24.35% 23.70%
EBITDA Margin
8.38% 10.39% 0.65% 5.33% 6.97% 4.94% 7.34% 7.38% 8.21% 9.79% 9.30%
Operating Margin
7.33% 8.55% 0.07% 2.24% 5.96% 3.77% 6.15% 6.42% 6.97% 8.45% 7.66%
EBIT Margin
7.38% 9.46% -0.33% 4.16% 5.84% 3.89% 6.34% 6.31% 7.02% 8.46% 7.83%
Profit (Net Income) Margin
4.00% 5.26% -1.11% 1.58% 3.00% 2.22% 3.89% 3.89% 4.40% 5.68% 5.35%
Tax Burden Percent
69.34% 67.26% 88.10% 48.16% 59.14% 66.42% 64.83% 68.59% 68.87% 70.93% 72.14%
Interest Burden Percent
78.16% 82.60% 387.54% 78.85% 86.81% 86.09% 94.75% 89.95% 91.01% 94.65% 94.60%
Effective Tax Rate
30.66% 32.74% 0.00% 51.84% 40.86% 33.58% 35.17% 31.41% 31.13% 29.07% 27.86%
Return on Invested Capital (ROIC)
20.78% 0.00% 0.00% 0.00% 14.92% 0.00% 0.00% 0.00% 24.53% 33.22% 29.00%
ROIC Less NNEP Spread (ROIC-NNEP)
19.38% 0.00% 0.00% 0.00% 12.37% 0.00% 0.00% 0.00% 21.84% 27.69% 26.29%
Return on Net Nonoperating Assets (RNNOA)
125.60% 0.00% 0.00% 0.00% 4.33% 0.00% 0.00% 0.00% 5.27% 2.49% 2.54%
Return on Equity (ROE)
146.38% 0.00% 0.00% 0.00% 19.25% 0.00% 0.00% 0.00% 29.80% 35.71% 31.54%
Cash Return on Invested Capital (CROIC)
-80.41% 0.00% 0.00% 0.00% -14.28% -5.09% 0.00% 0.00% 6.72% 4.80% 0.87%
Operating Return on Assets (OROA)
6.54% 0.00% 0.00% 0.00% 5.45% 0.00% 0.00% 0.00% 6.86% 8.24% 7.80%
Return on Assets (ROA)
3.54% 0.00% 0.00% 0.00% 2.80% 0.00% 0.00% 0.00% 4.30% 5.53% 5.32%
Return on Common Equity (ROCE)
138.32% 0.00% 0.00% 0.00% 18.97% 0.00% 0.00% 0.00% 29.59% 35.49% 31.36%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
43 54 0.50 11 43 32 52 59 65 85 79
NOPAT Margin
5.08% 5.75% 0.05% 1.08% 3.52% 2.50% 3.99% 4.40% 4.80% 5.99% 5.52%
Net Nonoperating Expense Percent (NNEP)
1.40% 1.32% 5.46% 0.00% 2.55% 0.87% 0.46% -596.10% 2.70% 5.52% 2.70%
Return On Investment Capital (ROIC_SIMPLE)
5.20% - - - 3.79% 2.76% 4.31% 4.81% 5.01% 6.38% 5.79%
Cost of Revenue to Revenue
79.66% 78.74% 77.62% 82.78% 78.60% 80.16% 77.98% 77.81% 76.49% 75.65% 76.30%
SG&A Expenses to Revenue
4.92% 5.02% 14.71% 6.88% 7.42% 7.73% 7.66% 7.63% 8.36% 7.91% 8.00%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
13.01% 12.71% 22.30% 14.98% 15.44% 16.07% 15.88% 15.77% 16.53% 15.90% 16.05%
Earnings before Interest and Taxes (EBIT)
63 88 -3.20 43 70 50 83 85 95 120 112
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
72 97 6.36 55 84 63 96 99 112 139 133
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
4.68 3.52 1.27 0.00 2.82 2.28 2.44 2.40 6.35 4.87 6.08
Price to Tangible Book Value (P/TBV)
14.59 7.18 1.43 0.00 3.11 2.51 2.66 2.60 6.84 5.21 6.47
Price to Revenue (P/Rev)
0.14 0.00 0.00 0.00 0.49 0.00 0.00 0.00 1.14 0.93 1.22
Price to Earnings (P/E)
3.99 0.00 0.00 0.00 35.83 0.00 0.00 0.00 31.39 20.71 25.07
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
25.08% 0.00% 0.00% 0.00% 2.79% 0.00% 0.00% 0.00% 3.19% 4.83% 3.99%
Enterprise Value to Invested Capital (EV/IC)
1.47 1.38 1.16 0.00 2.33 2.10 2.27 2.40 5.59 4.69 5.71
Enterprise Value to Revenue (EV/Rev)
0.36 0.00 0.00 0.00 0.55 0.00 0.00 0.00 1.17 0.94 1.23
Enterprise Value to EBITDA (EV/EBITDA)
4.67 0.00 0.00 0.00 11.88 0.00 0.00 0.00 16.60 11.39 14.14
Enterprise Value to EBIT (EV/EBIT)
5.38 0.00 0.00 0.00 15.45 0.00 0.00 0.00 19.73 13.30 16.58
Enterprise Value to NOPAT (EV/NOPAT)
7.48 0.00 0.00 0.00 33.61 0.00 0.00 0.00 29.61 19.49 23.69
Enterprise Value to Operating Cash Flow (EV/OCF)
17.50 0.00 0.00 0.00 6.14 0.00 0.00 0.00 15.26 10.40 11.92
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 88.73 108.47 745.70
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
7.20 5.87 0.85 0.00 0.57 0.53 0.49 0.40 0.37 0.28 0.22
Long-Term Debt to Equity
7.04 5.75 0.82 0.00 0.35 0.33 0.30 0.28 0.36 0.27 0.21
Financial Leverage
6.48 5.27 0.72 0.00 0.35 0.94 0.39 0.00 0.24 0.09 0.10
Leverage Ratio
34.53 28.94 6.74 0.00 10.71 10.68 6.96 6.42 6.49 6.20 5.79
Compound Leverage Factor
26.99 23.90 26.11 0.00 9.30 9.20 6.59 5.77 5.91 5.87 5.47
Debt to Total Capital
87.81% 85.45% 45.91% 0.00% 36.30% 34.82% 32.94% 28.72% 26.83% 21.96% 18.08%
Short-Term Debt to Total Capital
2.02% 1.83% 1.47% 0.00% 13.96% 13.35% 12.56% 8.74% 0.34% 0.63% 0.54%
Long-Term Debt to Total Capital
85.79% 83.62% 44.44% 0.00% 22.34% 21.47% 20.38% 19.99% 26.49% 21.33% 17.53%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.67% 0.61% 0.57% 0.00% 0.55% 0.52% 0.48% 0.45% 0.44% 0.38% 0.37%
Common Equity to Total Capital
11.52% 13.94% 53.52% 0.00% 63.15% 64.66% 66.58% 70.82% 72.73% 77.67% 81.56%
Debt to EBITDA
3.07 0.00 0.00 0.00 2.15 0.00 0.00 0.00 0.94 0.66 0.51
Net Debt to EBITDA
2.76 0.00 0.00 0.00 1.32 0.00 0.00 0.00 0.41 0.10 0.17
Long-Term Debt to EBITDA
3.00 0.00 0.00 0.00 1.32 0.00 0.00 0.00 0.93 0.64 0.49
Debt to NOPAT
4.91 0.00 0.00 0.00 6.08 0.00 0.00 0.00 1.68 1.12 0.85
Net Debt to NOPAT
4.42 0.00 0.00 0.00 3.73 0.00 0.00 0.00 0.73 0.17 0.28
Long-Term Debt to NOPAT
4.80 0.00 0.00 0.00 3.74 0.00 0.00 0.00 1.65 1.09 0.83
Altman Z-Score
1.15 0.29 0.27 0.00 1.11 0.28 0.00 0.00 1.87 1.78 2.03
Noncontrolling Interest Sharing Ratio
5.51% 4.19% 1.06% 0.00% 1.44% 1.35% 0.00% 0.00% 0.71% 0.62% 0.56%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.58 1.56 1.71 0.00 0.96 0.98 0.92 0.94 1.07 1.00 0.91
Quick Ratio
1.47 1.45 1.57 0.00 0.89 0.93 0.84 0.88 0.90 0.91 0.84
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -783 -995 0.00 0.00 -11 102 -815 -74 -129 -201
Operating Cash Flow to CapEx
-16.78% 65.86% 31.23% 324.81% 77.66% 848.02% 0.00% 0.00% -2.99% 218.13% 103.59%
Free Cash Flow to Firm to Interest Expense
0.00 -50.89 -108.33 0.00 0.00 -1.64 23.36 -95.61 -8.59 -20.15 -33.19
Operating Cash Flow to Interest Expense
-0.71 3.82 3.79 23.16 6.94 21.76 0.00 0.00 -0.40 36.79 22.43
Operating Cash Flow Less CapEx to Interest Expense
-4.91 -1.98 -8.35 16.03 -2.00 19.20 0.00 0.00 -13.63 19.92 0.78
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.89 0.00 0.00 0.00 0.93 0.00 0.00 0.00 0.98 0.97 0.99
Accounts Receivable Turnover
5.19 0.00 0.00 0.00 6.21 0.00 0.00 0.00 7.46 7.37 7.85
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
5.39 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.83 4.71 4.57
Accounts Payable Turnover
17.37 0.00 0.00 0.00 20.87 0.00 0.00 0.00 22.49 22.04 25.53
Days Sales Outstanding (DSO)
70.39 0.00 0.00 0.00 58.75 0.00 0.00 0.00 48.95 49.55 46.48
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
21.02 0.00 0.00 0.00 17.49 0.00 0.00 0.00 16.23 16.56 14.30
Cash Conversion Cycle (CCC)
49.37 0.00 0.00 0.00 41.26 0.00 0.00 0.00 32.72 32.99 32.18
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
761 837 996 0.00 966 873 918 875 1,105 1,087 1,197
Invested Capital Turnover
4.09 0.00 0.00 0.00 4.23 0.00 0.00 0.00 5.11 5.54 5.25
Increase / (Decrease) in Invested Capital
0.00 837 996 0.00 0.00 43 -50 875 139 215 279
Enterprise Value (EV)
1,115 1,159 1,151 0.00 2,254 1,836 2,080 2,096 6,170 5,098 6,835
Market Capitalization
450 450 727 6,091 1,998 1,713 1,969 2,092 6,012 5,048 6,749
Book Value per Share
$0.75 $0.99 $3.83 $0.00 $4.66 $4.92 $5.29 $5.72 $6.05 $6.60 $7.02
Tangible Book Value per Share
$0.24 $0.49 $3.39 $0.00 $4.22 $4.48 $4.85 $5.27 $5.61 $6.17 $6.59
Total Capital
834 918 1,069 0.00 1,124 1,160 1,212 1,230 1,302 1,335 1,361
Total Debt
733 785 491 0.00 408 404 399 353 349 293 246
Total Long-Term Debt
716 768 475 0.00 251 249 247 246 345 285 239
Net Debt
659 703 417 0.00 250 117 105 -2.30 152 45 82
Capital Expenditures (CapEx)
58 89 111 64 83 18 0.00 0.00 114 108 131
Debt-free, Cash-free Net Working Capital (DFCFNWC)
209 236 275 0.00 -41 -159 -232 -319 -124 -245 -250
Debt-free Net Working Capital (DFNWC)
282 317 348 0.00 117 129 62 37 73 2.97 -85
Net Working Capital (NWC)
265 300 333 0.00 -40 -26 -90 -71 68 -5.42 -93
Net Nonoperating Expense (NNE)
9.22 4.64 11 -5.15 6.38 3.59 1.22 6.84 5.42 4.47 2.52
Net Nonoperating Obligations (NNO)
659 703 417 0.00 250 117 105 -2.30 152 45 82
Total Depreciation and Amortization (D&A)
8.52 8.68 9.55 12 14 13 13 14 16 19 21
Debt-free, Cash-free Net Working Capital to Revenue
6.71% 0.00% 0.00% 0.00% -1.00% 0.00% 0.00% 0.00% -2.35% -4.51% -4.50%
Debt-free Net Working Capital to Revenue
9.06% 0.00% 0.00% 0.00% 2.85% 0.00% 0.00% 0.00% 1.38% 0.05% -1.54%
Net Working Capital to Revenue
8.52% 0.00% 0.00% 0.00% -0.98% 0.00% 0.00% 0.00% 1.29% -0.10% -1.67%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.28 $0.38 ($0.07) $0.00 $0.22 $0.18 $0.33 $0.33 $0.39 $0.51 $0.48
Adjusted Weighted Average Basic Shares Outstanding
128.72M 128.72M 149.46M 0.00 146.66M 155.18M 156.34M 156.58M 156.18M 157.07M 158.11M
Adjusted Diluted Earnings per Share
$0.28 $0.38 ($0.07) $0.00 $0.22 $0.17 $0.31 $0.32 $0.42 $0.50 $0.47
Adjusted Weighted Average Diluted Shares Outstanding
128.72M 128.72M 149.46M 0.00 148.57M 166.42M 165.47M 164.71M 156.70M 162.08M 161.99M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 24.64M 152.40M 0.00 0.00 0.00 0.00 156.62M 157.17M 158.27M 158.34M
Normalized Net Operating Profit after Tax (NOPAT)
43 54 0.50 16 43 32 52 59 65 85 79
Normalized NOPAT Margin
5.08% 5.75% 0.05% 1.57% 3.52% 2.50% 3.99% 4.40% 4.80% 5.99% 5.52%
Pre Tax Income Margin
5.77% 7.82% -1.26% 3.28% 5.07% 3.35% 6.00% 5.67% 6.39% 8.01% 7.41%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
4.58 5.75 -0.35 4.73 7.58 7.19 19.06 9.95 11.12 18.70 18.52
NOPAT to Interest Expense
3.15 3.49 0.05 1.23 4.58 4.63 11.99 6.94 7.60 13.25 13.05
EBIT Less CapEx to Interest Expense
0.38 -0.05 -12.48 -2.40 -1.36 4.62 0.00 0.00 -2.11 1.84 -3.13
NOPAT Less CapEx to Interest Expense
-1.05 -2.31 -12.08 -5.91 -4.37 2.06 0.00 0.00 -5.63 -3.61 -8.60
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
71.22% 0.00% 0.00% 0.00% 60.93% 0.00% 0.00% 0.00% 0.20% 0.24% 0.14%
Augmented Payout Ratio
71.22% 0.00% 0.00% 0.00% 60.93% 0.00% 0.00% 0.00% 0.20% 0.24% 0.14%

Financials Breakdown Chart

Key Financial Trends

PACS Group’s second-quarter 2026 results show continued revenue growth and improved profitability, although cash declined sharply during the quarter. Revenue reached $1.43 billion, up 9.1% from the restated second quarter of 2025 and slightly above the first quarter of 2026. The company’s longer-term growth trend remains strong, with quarterly revenue rising from $760.7 million in Q2 2023 to $1.43 billion in Q2 2026.

Profitability also improved year over year. Gross profit increased to $338.5 million, while the gross margin expanded to approximately 23.7% from 22.0% in Q2 2025. Operating income rose 35.8% to $109.3 million, and net income increased nearly 50% to $76.3 million. Diluted earnings per share improved to $0.47 from $0.31. However, sequentially, net income declined from $80.7 million in Q1 2026, and the diluted share count remains elevated at approximately 162.0 million shares.

Operating cash flow was solid but substantially lower than the prior quarter. PACS generated $135.5 million from operations in Q2 2026, compared with $52.6 million in Q2 2025 and $236.3 million in Q1 2026. Capital expenditures increased to $130.8 million, leaving estimated quarterly free cash flow of only about $4.7 million. For the first half of 2026, however, operating cash flow totaled approximately $371.8 million against $239.2 million of capital expenditures, producing positive estimated free cash flow of roughly $132.6 million.

The balance sheet presents a mixed picture. Cash and equivalents fell from $248.0 million at the end of Q1 2026 to $164.5 million at the end of Q2. Total debt, including short- and long-term borrowings, declined to approximately $246.1 million from $293.2 million in the prior quarter. Nevertheless, total liabilities were $4.54 billion compared with $1.12 billion of equity, and the current ratio remained below 1.0, indicating limited short-term balance-sheet flexibility.

  • Revenue continues to expand: Q2 2026 revenue increased 9.1% year over year and has grown substantially from $760.7 million in Q2 2023.
  • Profitability improved: Gross margin expanded to approximately 23.7%, while operating margin rose to about 7.7% from 6.1% in Q2 2025.
  • Net income and EPS accelerated: Net income rose nearly 50% year over year to $76.3 million, and diluted EPS increased to $0.47 from $0.31.
  • Operating cash flow strengthened year over year: Q2 operating cash flow more than doubled from $52.6 million to $135.5 million.
  • Debt declined sequentially: Total short- and long-term debt fell by approximately $47 million from Q1 2026 to Q2 2026.
  • Free cash flow was approximately breakeven in Q2: Heavy capital spending largely absorbed operating cash flow, although first-half 2026 free cash flow remained positive.
  • Cash remains above 2024 levels: Despite the recent decline, Q2 cash of $164.5 million was well above the $49.5 million reported in Q3 2024.
  • Cash declined sharply during the quarter: PACS reported a $96.8 million decrease in cash, driven by investing and financing outflows.
  • Capital spending remains intensive: Q2 property and equipment purchases totaled $130.8 million, while total investing cash outflow reached $155.7 million.
  • Balance-sheet leverage and liquidity require monitoring: Total liabilities significantly exceed equity, and current liabilities of $1.06 billion were greater than current assets of $962.4 million.
09/10/26 05:34 PM ETAI Generated. May Contain Errors.

PACS Group Financials - Frequently Asked Questions

According to the most recent income statement we have on file, PACS Group's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

PACS Group's net income appears to be on an upward trend, with a most recent value of $191.46 million in 2025, rising from $150.50 million in 2022. The previous period was $55.34 million in 2024. Find out what analysts predict for PACS Group in the coming months.

PACS Group's total operating income in 2025 was $309.60 million, based on the following breakdown:
  • Total Gross Profit: $1.16 billion
  • Total Operating Expenses: $849.64 million

Over the last 3 years, PACS Group's total revenue changed from $2.42 billion in 2022 to $5.29 billion in 2025, a change of 118.4%.

PACS Group's total liabilities were at $4.63 billion at the end of 2025, a 2.3% increase from 2024, and a 35.8% increase since 2023.

In the past 2 years, PACS Group's cash and equivalents has ranged from $73.42 million in 2023 to $197.02 million in 2025, and is currently $197.02 million as of their latest financial filing in 2025.

Over the last 3 years, PACS Group's book value per share changed from 0.00 in 2022 to 6.05 in 2025, a change of 604.5%.



Financial statements for NYSE:PACS last updated on 8/4/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners